APA (7th ed.) Citation

Del Re, M., Conteduca, V., Crucitta, S., Gurioli, G., Casadei, C., Restante, G., . . . De Giorgi, U. (2019). 93PD - Analysis of the androgen receptor status in liquid biopsy to predict the outcome to abiraterone and enzalutamide in CRPC patients. Annals of Oncology, 30, v26. https://doi.org/10.1093/annonc/mdz239.004

Chicago Style (17th ed.) Citation

Del Re, M., et al. "93PD - Analysis of the Androgen Receptor Status in Liquid Biopsy to Predict the Outcome to Abiraterone and Enzalutamide in CRPC Patients." Annals of Oncology 30 (2019): v26. https://doi.org/10.1093/annonc/mdz239.004.

MLA (9th ed.) Citation

Del Re, M., et al. "93PD - Analysis of the Androgen Receptor Status in Liquid Biopsy to Predict the Outcome to Abiraterone and Enzalutamide in CRPC Patients." Annals of Oncology, vol. 30, 2019, p. v26, https://doi.org/10.1093/annonc/mdz239.004.